DEFA-1 and ITGAM and were inversely associated with HCC when compared to cirrhotic participants, potentially suggesting a bi-directional effect of these markers during the natural progression of disease among HCV infected individuals. This evidence concerns the gene DEFA1 and hepatocellular carcinoma.